NuVasive, Inc. (NUVA) – Financial and Strategic SWOT Analysis Review

NuVasive, Inc. (NUVA) – Financial and Strategic SWOT Analysis Review Cover

Single Licence: $125

Buy Now
customer(s) bought this report
BUY WITH CONFIDENCE

Shopping on CFDMaster.com is Safe and Secure. GUARANTEED!
All information is encrypted and handled by PayPal.com

Need Assistance?
Have you got questions about this report? Why not speak to one of our advisors. Email us at business@cfdmaster.com or call us at +61 (02) 8011 3208
# Pages
Market
Country
Single User
Site License
Enterprisewide
54
Medical Devices
United States

NuVasive, Inc. (NUVA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NuVasive, Inc. (NuVasive) is a medical device company. It offers an extensive selection of minimally-disruptive surgical products, and procedurally-integrated solutions for the spine. The company’s product portfolio focuses on spine fusion surgery including cervical surgery and thoracolumbar surgery. NuVasive’s principal product offering includes a minimally-disruptive surgical platform, namely, maximum access surgery (MAS). Under this platform, the company offers three categories of solutions, nerve detection and avoidance systems, intra-operative monitoring (IOM) services and support; and MaXcess, an integrated split-blade retractor system, and various specialized implants and biologics. These products facilitate surgeon’s access to the spine to perform restorative and fusion procedures in a minimally-disruptive fashion; and aid in spinal fusion or bone healing process. The company offers its products in various markets across the Americas, Asia-Pacific, and Europe. NuVasive is headquartered in San Diego, California, the US.

The company seeks to focus on improving and developing new product offerings to maintain its financial strength. To this end, NuVasive launched NVM5 V2.0, a next generation monitoring platform for spine surgery.

NuVasive, Inc. Key Recent Developments

Mar 03, 2015: NuVasive Announces Successful Appeal of Medtronic Verdict
Feb 24, 2015: NuVasive Reports Fourth Quarter and Full Year 2014 Financial Results
Jan 12, 2015: NuVasive Announces Expanded Leadership Roles for Executives Pat Miles and Matt Link
Jan 12, 2015: NuVasive Announces Select Preliminary Unaudited Full-Year 2014 Financial Results and 2015 Outlook
Dec 30, 2013: NuVasive to Present at J.P. Morgan Healthcare Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Table of Contents

Section 1 – About the Company 6
NuVasive, Inc. – Key Facts 6
NuVasive, Inc. – Key Employees 7
NuVasive, Inc. – Key Employee Biographies 8
NuVasive, Inc. – Major Products and Services 9
NuVasive, Inc. – Medical Equipment Pipeline Products Data 11
NuVasive, Inc. Pipeline Products by Equipment Type 11
NuVasive, Inc. Pipeline Products by Development Stage 13
NuVasive, Inc. – History 15
NuVasive, Inc. – Company Statement 18
NuVasive, Inc. – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Section 2 – Company Analysis 23
NuVasive, Inc. – Business Description 23
NuVasive, Inc. – Corporate Strategy 24
NuVasive, Inc. – SWOT Analysis 25
SWOT Analysis – Overview 25
NuVasive, Inc. – Strengths 25
Strength – Focus on Research and Development 25
Strength – Strong Presence: Global Spine Market 25
Strength – The NuVasive Solution 25
NuVasive, Inc. – Weaknesses 27
Weakness – Single Source Suppliers 27
Weakness – Product Safety Concerns 27
Weakness – Patent and Trademark Infringements 27
NuVasive, Inc. – Opportunities 28
Opportunity – Expansion Initiatives in EMEA 28
Opportunity – Positive Outlook: Global Spinal Surgery Market 28
Opportunity – Growing International Healthcare Access 28
NuVasive, Inc. – Threats 29
Threat – Competition 29
Threat – Foreign Trade Regulations 29
Threat – Changing Third-party Reimbursement Policies 29
NuVasive, Inc. – Key Competitors 30
Section 3 – Company Financial Ratios 31
Financial Ratios – Capital Market Ratios 31
Financial Ratios – Annual Ratios 32
Performance Chart 33
Financial Performance 33
Financial Ratios – Interim Ratios 34
Financial Ratios – Ratio Charts 35
Section 4 – Company’s Lifesciences Financial Deals and Alliances 36
NuVasive, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 36
NuVasive, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015 37
NuVasive, Inc., Recent Deals Summary 38
Section 5 – Company’s Recent Developments 39
Mar 03, 2015: NuVasive Announces Successful Appeal of Medtronic Verdict 39
Feb 24, 2015: NuVasive Reports Fourth Quarter and Full Year 2014 Financial Results 40
Jan 12, 2015: NuVasive Announces Expanded Leadership Roles for Executives Pat Miles and Matt Link 41
Jan 12, 2015: NuVasive Announces Select Preliminary Unaudited Full-Year 2014 Financial Results and 2015 Outlook 43
Nov 24, 2014: NuVasive To Participate In Investor Events In December 2014 44
Nov 10, 2014: NuVasive Focused on Surgeon Support and Showcasing Industry-Leading Products at North American Spine Society 29th Annual Meeting 45
Oct 30, 2014: NuVasive Reports Third Quarter 2014 Financial Results and Increases Full Year Guidance 46
Oct 01, 2014: NuVasive Demonstrates Expanding EMEA Business at Eurospine 2014 With Surgeon Workshops and Innovative Product Exhibition 47
Sep 08, 2014: NuVasive Spine Foundation Exceeds $13 Million in Global Effort to Support Patients in Need 48
Aug 26, 2014: MNX Global Logistics renews multi-year contract with NuVasive 49
Section 6 – Appendix 50
Methodology 50
Ratio Definitions 50
About GlobalData 54
Contact Us 54
Disclaimer 54



List of Tables
NuVasive, Inc., Key Facts 6
NuVasive, Inc., Key Employees 7
NuVasive, Inc., Key Employee Biographies 8
NuVasive, Inc., Major Products and Services 9
NuVasive, Inc. Number of Pipeline Products by Equipment Type 11
NuVasive, Inc. Pipeline Products by Equipment Type 12
NuVasive, Inc. Number of Pipeline Products by Development Stage 13
NuVasive, Inc. Pipeline Products by Development Stage 14
NuVasive, Inc., History 15
NuVasive, Inc., Other Locations 21
NuVasive, Inc., Subsidiaries 21
NuVasive, Inc., Key Competitors 30
NuVasive, Inc., Ratios based on current share price 31
NuVasive, Inc., Annual Ratios 32
NuVasive, Inc., Interim Ratios 34
NuVasive, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 36
NuVasive, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015 37
NuVasive, Inc., Recent Deals Summary 38
Currency Codes 50
Capital Market Ratios 50
Equity Ratios 51
Profitability Ratios 51
Cost Ratios 52
Liquidity Ratios 52
Leverage Ratios 53
Efficiency Ratios 53



List of Figures
NuVasive, Inc. Pipeline Products by Equipment Type 11
NuVasive, Inc. Pipeline Products by Development Stage 13
NuVasive, Inc., Performance Chart (2010 – 2014) 33
NuVasive, Inc., Ratio Charts 35
NuVasive, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015 36
NuVasive, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015 37

Report Delivery

PDF SWOT Analysis Report An Electronic PDF copy of this Report will be sent to you via email.

Please allow up to 2 business days for the reports to arrive to your mailbox as some of our publishers prefer to send you the reports directly.

Purchase this Report today

Price: $125

Report Licences Explanation

* Single User: Electronic PDF copy delivered via email. Report can be used by individual purchaser only.

* Site License: Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.

* Enterprise Wide License: Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.

If you require a Site License or Enterprise Wide License please contact us to issue you an invoice.

Customers who Viewed this Report also Viewed

Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.